Department of Pediatric Hematology, Oncology, and Immunology, University of Heidelberg, Heidelberg, Germany.
J Clin Invest. 2011 Apr;121(4):1386-96. doi: 10.1172/JCI44883.
Systemic iron homeostasis is mainly controlled by the liver through synthesis of the peptide hormone hepcidin (encoded by Hamp), the key regulator of duodenal iron absorption and macrophage iron release. Here we show that the liver-specific microRNA miR-122 is important for regulating Hamp mRNA expression and tissue iron levels. Efficient and specific depletion of miR-122 by injection of a locked-nucleic-acid-modified (LNA-modified) anti-miR into WT mice caused systemic iron deficiency, characterized by reduced plasma and liver iron levels, mildly impaired hematopoiesis, and increased extramedullary erythropoiesis in the spleen. Moreover, miR-122 inhibition increased the amount of mRNA transcribed by genes that control systemic iron levels, such as hemochromatosis (Hfe), hemojuvelin (Hjv), bone morphogenetic protein receptor type 1A (Bmpr1a), and Hamp. Importantly, miR-122 directly targeted the 3′ untranslated region of 2 mRNAs that encode activators of hepcidin expression, Hfe and Hjv. These data help to explain the increased Hamp mRNA levels and subsequent iron deficiency in mice with reduced miR-122 levels and establish a direct mechanistic link between miR-122 and the regulation of systemic iron metabolism.
系统性铁稳态主要由肝脏通过合成肽激素铁调素(由 Hamp 编码)来控制,铁调素是十二指肠铁吸收和巨噬细胞铁释放的关键调节剂。在这里,我们表明,肝脏特异性 microRNA miR-122 对于调节 Hamp mRNA 表达和组织铁水平很重要。通过向 WT 小鼠注射锁核酸修饰(LNA 修饰)的抗 miR 来有效且特异性地耗尽 miR-122 会导致系统性缺铁,其特征为血浆和肝脏铁水平降低、造血功能轻度受损以及脾脏中骨髓外红细胞生成增加。此外,miR-122 抑制增加了控制系统性铁水平的基因转录的 mRNA 量,例如血色病(Hfe)、珠蛋白生成素(Hjv)、骨形态发生蛋白受体 1A(Bmpr1a)和 Hamp。重要的是,miR-122 直接靶向编码铁调素表达激活剂的 2 个 mRNA 的 3'非翻译区,即 Hfe 和 Hjv。这些数据有助于解释 miR-122 水平降低的小鼠中 Hamp mRNA 水平升高和随后的缺铁,并建立了 miR-122 与系统性铁代谢调节之间的直接机制联系。